Picture [iito] Made Without Love 650x80px
Document › Details

Univercells S.A.. (6/25/18). "Press Release: Univercells Appoints Christian Borgniet as Chief Operating Officer". Brussels.

Organisations Organisation Univercells S.A.
  Group Univercells (Group)
  Organisation 2 Zoetis (Group)
Products Product biopharmaceutical production
  Product 2 biopharmaceutical production technology
Persons Person Borgniet, Christian (Univercells 201806 COO– before Pfizer/Zoetis + SKB)
  Person 2 Bultot, Hugues (Univercells 2013– CEO + Co-Founder)

Mr. Borgniet brings to the table his twenty-five years of broad industry experience and knowledge garnered while working and evolving in roles within all aspects and phases of manufacturing during his years at Pfizer/ Zoetis and SmithKline Beecham.

Univercells SA, a technology company dedicated to delivering innovative and cost-effective biomanufacturing solutions, today formally announces the appointment of Christian Borgniet as its new Chief Operating Officer.

A well-versed biopharmaceutical veteran, Christian Borgniet joins Univercells to support strategy implementation and operations planning, reinforcing long-term company objectives and development of its technological solutions.

As COO, Christian will be leading the operations in its Gosselies and Nivelles facilities, overseeing operational activities, leading its teams to assure the proper management and delivery of development projects.

Mr. Borniet has already successfully managed several industrial projects, including the opening of Pfizer Animal Health’s first R&D pilot plant for vaccines, and the US FDA certification of Zoetis’ first site for the manufacture and supply of veterinary vaccines.

As Site Leader and Managing Director at Pfizer/Zoetis, he oversaw the establishment of a GMP plant under a 22M€ investment, for a first-in-kind entirely disposable BSL3 plant for antigens.

These significant achievements set Borgniet on a trajectory to drive the operational development of Univercells’ manufacturing platform for the cost-effective production of vaccines and antibodies.

Christian Borgniet, COO of Univercells: “I have found the evolution of Univercells very exciting and promising to watch, especially its potential impact on global health via technology and innovation. I am excited to be a part of Univercells’ game-changing mission and by my role in its organization. I see myself as an ‘orchestra conductor’ who translates leadership’s vision to our team of ‘musicians,’ to lead them in the right direction, harmonizing operations through continuous improvement philosophy, execution, and delivery.”

Hugues Bultot, CEO of Univercells: “We are delighted to welcome an experienced executive bringing such strong industry expertise to drive Univercells’ operations. I truly believe Christian’s enthusiasm for his role along with his incredible skill set and years of experience working in biomanufacturing will prove an invaluable asset as we continue to deliver our strategy towards making a real impact towards biologics for all.”

Record changed: 2018-08-04


Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Univercells (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group Global Partnering Four Events One Price 650x80

» top